| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.28 | 0.09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.09 |